This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Ottawa directory, so their courses and email address may be missing. Find their university profile.
Research
Latest papers
Helping Underdeveloped Lungs with Cells (HULC-2): mesenchymal stromal cells in extreme preterm infants at risk of developing bronchopulmonary dysplasia - a study protocol of a phase 2 multicentre double blind randomised controlled trial in Canada.
BMJ open · 2026
Targeted Intra-Atrial Delivery of GMP-Grade Human Extracellular Vesicles Prevents Inflammation-Driven Postoperative Atrial Fibrillation in Pigs.
JACC. Basic to translational science · 2026
Human atrial extracellular vesicles suppress NLRP3 inflammasome activation and profibrotic signaling in a patient-specific iPSC model of postoperative atrial fibrillation.
Theranostics · 2026
Latest funding
- $575,163
Helping Underdeveloped Lungs with Cells (HULC-2) - A Randomized Controlled Trial to test the efficacy of umbilical cord-derived mesenchymal stromal cells (UC-MSC) in reducing respiratory morbidity in preterm infants at risk of bronchopulmonary dysplasia (BPD)
CIHR · 2023 · Co-investigator
- $2,300,649
Helping Underdeveloped Lungs with Cells (HULC-2) - A Randomized Controlled Trial to test the efficacy of umbilical cord-derived mesenchymal stromal cells (UC-MSC) in reducing respiratory morbidity in preterm infants at risk of bronchopulmonary dysplasia (BPD)
CIHR · 2023 · Co-investigator
- $50,000
COVID-19 Variant Supplement - Cellular Immuno-Therapy for COVID-19 Induced Acute Respiratory Distress Syndrome: the CIRCA-19 Trial
CIHR · 2021 · Co-investigator
13 publications.
Helping Underdeveloped Lungs with Cells (HULC-2): mesenchymal stromal cells in extreme preterm infants at risk of developing bronchopulmonary dysplasia - a study protocol of a phase 2 multicentre double blind randomised controlled trial in Canada.
Renesme L, Ferretti E, Horth C, Grimwood R, Da Sylva L, Olson V, Cyr-Depauw C, Freund D, Rüdiger M, Möbius MA, Hodgins S, Khan S, Courtman D, Fergusson DA, Thebaud B
Targeted Intra-Atrial Delivery of GMP-Grade Human Extracellular Vesicles Prevents Inflammation-Driven Postoperative Atrial Fibrillation in Pigs.
Ahmed N, Parent S, René CA, Kovacina N, St Amant J, Napoleone M, Collet B, Kahn S, Courtman D, Stewart DJ, Chan V, Davis DR
Human atrial extracellular vesicles suppress NLRP3 inflammasome activation and profibrotic signaling in a patient-specific iPSC model of postoperative atrial fibrillation.
Ahmed N, Ye B, Liang W, Lam BK, Rubens F, Khan S, Courtman D, Stewart DJ, Davis DR
Atrial Fibrosis and Inflammation in Postoperative Atrial Fibrillation: Comparative Effects of Amiodarone, Colchicine, or Exosomes.
Parent S, Amant JS, Remortel SV, Kahn S, Vaka R, Courtman D, Stewart DJ, Davis DR
Inactivation of the NLRP3 inflammasome mediates exosome-based prevention of atrial fibrillation.
Parent S, Vaka R, St Amant J, Kahn S, Van Remortel S, Bi C, Courtman D, Stewart DJ, Davis DR
Metabolomics Analysis of Mesenchymal Stem Cell (MSC) Therapy in a Phase I Clinical Trial of Septic Shock: An Exploratory Study.
Banoei MM, McIntyre LA, Stewart DJ, Mei SHJ, Courtman D, Watpool I, Granton J, Marshall J, Dos Santos C, Walley KR, Schlosser K, Fergusson DA, Winston BW, On Behalf Of Canadian Critical Care Trials Group Ccctg, On Behalf Of Canadian Critical Care Translational Biology Group Ccctbg
Prevention of atrial fibrillation after open-chest surgery with extracellular vesicle therapy.
Parent S, Vaka R, Risha Y, Ngo C, Kanda P, Nattel S, Khan S, Courtman D, Stewart DJ, Davis DR
Extracellular vesicle microRNA and protein cargo profiling in three clinical-grade stem cell products reveals key functional pathways.
Vaka R, Parent S, Risha Y, Khan S, Courtman D, Stewart DJ, Davis DR
Direct comparison of different therapeutic cell types susceptibility to inflammatory cytokines associated with COVID-19 acute lung injury.
Vaka R, Khan S, Ye B, Risha Y, Parent S, Courtman D, Stewart DJ, Davis DR
Deterministic paracrine repair of injured myocardium using microfluidic-based cocooning of heart explant-derived cells.
Kanda P, Benavente-Babace A, Parent S, Connor M, Soucy N, Steeves A, Lu A, Cober ND, Courtman D, Variola F, Alarcon EI, Liang W, Stewart DJ, Godin M, Davis DR
Helping Underdeveloped Lungs with Cells (HULC-2) - A Randomized Controlled Trial to test the efficacy of umbilical cord-derived mesenchymal stromal cells (UC-MSC) in reducing respiratory morbidity in preterm infants at risk of bronchopulmonary dysplasia (BPD)
Principal investigators: Thebaud, Bernard; Robeson, Paula; Fergusson, Dean A
Keywords: Clinical Trial; Lung Injury; Mesenchymal Stromal Cells; Newborn; Outcome; Preterm Birth; Regenerative Medicine; Stem Cells
Helping Underdeveloped Lungs with Cells (HULC-2) - A Randomized Controlled Trial to test the efficacy of umbilical cord-derived mesenchymal stromal cells (UC-MSC) in reducing respiratory morbidity in preterm infants at risk of bronchopulmonary dysplasia (BPD)
Principal investigators: Thebaud, Bernard; Robeson, Paula; Fergusson, Dean A
Keywords: Clinical Trial; Lung Injury; Mesenchymal Stromal Cells; Newborn; Outcome; Preterm Birth; Regenerative Medicine; Stem Cells
COVID-19 Variant Supplement - Cellular Immuno-Therapy for COVID-19 Induced Acute Respiratory Distress Syndrome: the CIRCA-19 Trial
Principal investigators: Stewart, Duncan J; English, Shane W; Fergusson, Dean A
Keywords: Acute Respiratory Distress Syndrome; Adults; Biological Outcomes; Clinical Outcomes; Covid-19; Mechanical Ventilation; Mesenchymal Stromal Cells; Phase Ii; Placebo Controlled; Randomized Controlled Trial
Cellular Immuno-Therapy for COVID-19 Induced Acute Respiratory Distress Syndrome: the CIRCA-19 Trial
Principal investigators: Stewart, Duncan J; English, Shane W; Fergusson, Dean A
Keywords: Acute Respiratory Distress Syndrome; Adults; Biological Outcomes; Clinical Outcomes; Covid-19; Mechanical Ventilation; Mesenchymal Stromal Cells; Phase Ii; Placebo Controlled; Randomized Controlled Trial
Enhancing cell therapies using microfluidic encapsulation strategies
Principal investigators: Godin, Michel; Courtman, David W; Davis, Darryl R; Stewart, Duncan J
Keywords: Biomaterials; Cardiopulmonary Disease; Cell Encapsulation; Cell-Based Therapies; Hydrogel; Microfluidic Devices
Cellular Immunotherapy in Septic Shock: A Meeting to Develop a Stem Cell in Sepsis International Collaborative Network
Principal investigators: McIntyre, Lauralyn A; Fergusson, Dean A
Keywords: Biological Data; International Meeting; Mesenchymal Stem Cells; Mesenchymal Stromal Cells; Network; Randomized Controlled Trial; Septic Shock
Cellular Immunotherapy for Septic Shock (CISS): A Phase II Trial
Principal investigators: McIntyre, Lauralyn A; Fergusson, Dean A
Keywords: Biological Outcomes; Clinical Outcomes; Mesenchymal Stem Cells (Mscs); Multi-Centre; Multi-Organ Dysfunction; Phase Ii Trial; Randomized Controlled Trial; Septic Shock
Cocooning Therapeutic Cells
Principal investigators: Godin, Michel
From endothelial biology to meaningful clinical impact
Principal investigators: Stewart, Duncan J
Keywords: Acute Lung Injury; Angiogenesis; Angiopoetins; Endothelial Cells; Endothelial Progenitor Cells; Gene Transfer; Microrna; Randomized Trials; Stem Cells; Vascular Inflammation
Cocooning Therapeutic Cells
Principal investigators: Godin, Michel; Courtman, David W; Davis, Darryl R; Harden, James L
Keywords: Cardiopulmunary Disease; Cell Encapsulation; Cell Engraftment; Cell-Based Therapies; Hydrogel; Lab-On-A-Chip; Microfabrication; Microfluidic Devices; Therapeutic Cells
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
Frequent collaborators
- John Granton and John Marshall: 5 shared papers
- Claudia Dos Santos and John Marshall: 4 shared papers
- John Granton and Claudia Dos Santos: 2 shared papers
- Claudia Dos Santos and David Courtman: 2 shared papers
- David Courtman and John Marshall: 2 shared papers
- David Courtman and Wenbin Liang: 2 shared papers
- John Granton and David Courtman: 1 shared paper
- Bernard Thébaud and David Courtman: 1 shared paper
- Bernard Thébaud and Emanuela Ferretti: 1 shared paper
- Michel Godin and David Courtman: 1 shared paper
- Michel Godin and Wenbin Liang: 1 shared paper
- David Courtman and Fraser Rubens: 1 shared paper
- David Courtman and Stanley Nattel: 1 shared paper
- David Courtman and Emanuela Ferretti: 1 shared paper
- Fraser Rubens and Wenbin Liang: 1 shared paper
- Critical Care Medicine
- Pediatrics
- Cellular and Molecular Medicine
- Surgery
- Medicine/Respirology
- Medicine
- Other
Co-authors at University of Ottawa, colored by department. Thicker lines mean more shared papers; select anyone to open their profile and their own map.
John Marshall
Critical Care Medicine
2 shared papers, latest 2023
Wenbin Liang
Cellular and Molecular Medicine
2 shared papers, latest 2026
Claudia Dos Santos
Critical Care Medicine
2 shared papers, latest 2023
Fraser Rubens
Surgery
1 shared papers, latest 2026
Stanley Nattel
Medicine
1 shared papers, latest 2023
Emanuela Ferretti
Pediatrics
1 shared papers, latest 2026
John Granton
Medicine/Respirology
1 shared papers, latest 2023
Bernard Thébaud
Pediatrics
1 shared papers, latest 2026
Michel Godin
Faculty
1 shared papers, latest 2020
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.